Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Apperley

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Leukemia|March 16, 2007
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacyM P Simula, S Marktel, C Fozza, et al.
Cell Proliferation|January 10, 2008
Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver diseaseN Levicar, M Pai, N A Habib, et al.
Leukemia|July 30, 2003
Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfaD Marin, S Marktel, M Bua, et al.
Blood|May 26, 1999
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMTE F Posthuma, J H Falkenburg, J F Apperley, et al.
Bone Marrow Transplantation|June 27, 2017
Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservationJ Pavlů, H W Auner, R M Szydlo, et al.
Bone Marrow Transplantation|October 12, 2011
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSFG W Basak, W Wiktor-Jedrzejczak, J F Apperley, et al.
Bone Marrow Transplantation|June 19, 1998
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow TransplantationN Schmitz, A Bacigalupo, D Hasenclever, et al.
Bone Marrow Transplantation|November 15, 2011
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilizationK Hübel, M M Fresen, J F Apperley, et al.
Bone Marrow Transplantation|February 26, 2014
Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHDF L Dignan, S Aguilar, J J Scarisbrick, et al.
Bone Marrow Transplantation|September 20, 2011
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHDF L Dignan, D Greenblatt, M Cox, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Leukemia|March 16, 2007
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacyM P Simula, S Marktel, C Fozza, et al.
Cell Proliferation|January 10, 2008
Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver diseaseN Levicar, M Pai, N A Habib, et al.
Leukemia|July 30, 2003
Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfaD Marin, S Marktel, M Bua, et al.
Blood|May 26, 1999
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMTE F Posthuma, J H Falkenburg, J F Apperley, et al.
Bone Marrow Transplantation|June 27, 2017
Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservationJ Pavlů, H W Auner, R M Szydlo, et al.
Bone Marrow Transplantation|October 12, 2011
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSFG W Basak, W Wiktor-Jedrzejczak, J F Apperley, et al.
Bone Marrow Transplantation|June 19, 1998
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow TransplantationN Schmitz, A Bacigalupo, D Hasenclever, et al.
Bone Marrow Transplantation|November 15, 2011
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilizationK Hübel, M M Fresen, J F Apperley, et al.
Bone Marrow Transplantation|February 26, 2014
Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHDF L Dignan, S Aguilar, J J Scarisbrick, et al.
Bone Marrow Transplantation|September 20, 2011
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHDF L Dignan, D Greenblatt, M Cox, et al.
Pageof 14